QNRX (Quoin Pharmaceuticals Ltd) קפיטליזציה חשבונאית

The price action of Quoin Pharmaceuticals (QNRX) allows for an assessment of how FDA approvals impact the resilience of a business led by seasoned experts with a transparent development roadmap. This metric stands at 0.00, supporting the development of treatments for rare skin pathologies, which will ensure stable demand due to the chronic nature of these ailments. Operational efficiency is further enhanced by streamlined raw material delivery routes via specialized hubs.

This indicator represents the difference between total assets and all financial liabilities, reflecting the actual value of the company's own property excluding market speculation. Assessing the level of the enterprise's balance sheet capital provides insight into the financial stability of Quoin Pharmaceuticals (QNRX), whose business profile is constrained by strict compliance with laboratory environmental standards, which minimizes the risk of unforeseen costs and stabilizes the chart's dynamics.